Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort.

Autor: Peng Y; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona; Department of Oncology, Fangshan Hospital, Beijing University of Chinese Medicine, Beijing, China., Kumar AV; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona., Gu Z; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona., Kosuru N; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona., Wampfler JA; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Reck Dos Santos PA; Division of Thoracic Surgery, Mayo Clinic, Scottsdale, Arizona., Yu NY; Department of Radiation Oncology, Mayo Clinic, Scottsdale, Arizona., D'Cunha J; Division of Thoracic Surgery, Mayo Clinic, Scottsdale, Arizona., Ernani V; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Scottsdale, Arizona., Costello CM; Department of Dermatology, Mayo Clinic, Scottsdale, Arizona., Yang P; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona. Electronic address: Yang.Ping@mayo.edu.
Jazyk: angličtina
Zdroj: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Jul; Vol. 91 (1), pp. 172-175. Date of Electronic Publication: 2024 Mar 29.
DOI: 10.1016/j.jaad.2024.03.029
Abstrakt: Competing Interests: Conflicts of interest None disclosed.
Databáze: MEDLINE